da Martina Zanero | Nov 12, 2024 | News
At TCT2024 on Tuesday, October 29, Dr. Torsten Vahl from Columbia University Irving Medical Center reviewed the first 3 patients in CASSINI-EU EFS study on Saturn Trans-septal TMVR System in the presentation ‘Novel TMVR Systems on the Launchpad’ during ‘TCT Innovation...
da Martina Zanero | Ago 8, 2024 | News
Annals of Thoracic Surgery Short Reports just published Early Feasibility Study with the SATURN Transapical Mitral Valve Replacement Device, available at https://doi.org/10.1016/j.atssr.2024.06.011. Deep gratitude and congratulation to the authors: Prof. Kęstutis...
da Martina Zanero | Giu 17, 2024 | News
Our technology and first trans-septal implant have been presented at NY Valves 2024 held on June 5-7 in Jacob K. Javits Convention Center, New York. Specifically, Dr. Lauren S. Ranard, MD from Columbia University Irving Medical Center, held a presentation named...
da Martina Zanero | Mag 30, 2024 | Press release
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 year old female suffering from severe mixed (degenerative and functional)...
da Martina Zanero | Mar 12, 2024 | News
Eurointervention, the official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), published preclinical data on our novel, investigational Saturn TMVR device in the article Procedural performance and healing response...
